Bipolar II Disorder clinical trials at UC Cancer

1 research study open to eligible people

Psilocybin Therapy for Depression in Bipolar II Disorder
open to eligible people ages 30-65
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.
at UCSF

Our lead scientists for Bipolar II Disorder research studies include Joshua D Woolley, MD,PhD.

Last updated: January 2022